Make your money go further for just 25p per day

AIM IHT

A tale of 2 investment managers

Sustainability

There were positive trading updates from companies covered here, including a couple of relative newcomers to AIM, as well as two investment managers commanding very different valuations. (Free to read)


Cambridge Cognition: major new pharma client

Cambridge Cognition (AIM: COG), which develops and markets digital solutions to assess brain health, has been awarded contracts for two clinical trials by a top 20 pharmaceutical company to assess the pro-cognitive effects of a new drug in schizophrenia. Together the contracts are worth £700,000 over two years.

This is the second pharmaceutical client to award Cambridge Cognition major contracts for cognitive assessments for schizophrenia in…

Sign up and read the full article

Register to continue reading our content.

Get FREE access now

Already a member? Login


Previous article Next article

Have your say

Log in or register to view or add comments.

DON'T MISS OUT!

Get top investment ideas to help safeguard and grow your wealth.

Invaluable insight from the exciting world of smaller companies.

REGISTER FREE

DON'T MISS OUT ON OUR PREMIUM CONTENT

Become a champion investor for just £90 a year. Benefit from our high performing portfolios:

START FREE TRIAL

More on Cambridge Cognition

Load of waffle | Uranium is hot | Contract wins

06/02/2023 · Company Insights

News and updates covered here include a questionable justification for the sale of two fast-growing companies…


Quality going cheap | Dividend joy

31/01/2023 · Company Insights

Results and updates covered here include one of the most forthright announcements we have seen from…


More on Impax Asset Management

Video game nightmares

10/01/2023 · Company Insights

Another big profit warning from one of AIM’s video gaming groups saw the shares tumble, we…


Bonkers Bargains | Festive Fears | Contract wins

01/12/2022 · Company Insights

Results and updates covered here include positive news from one of our Bonkers Bargain opportunities, but…


More on Premier Miton Group

Whopping dividends from AIM

13/01/2023 · Company Insights

Updates covered here include several AIM and small cap companies offering high dividend payouts. While some…


9%+ dividend yield, but is it sustainable?

02/12/2022 · Company Insights

News from AIM covered here include results from a cash rich AIM company where the forecast dividend…


More on Quartix Technologies

Roll up for recurring revenue appeal

27/02/2023 · Company Insights

A cracking little company covered in our free update here should start to see strong revenue…


Change in accounting policy!

12/01/2023 · Company Insights

A profitable fast-growing AIM company covered here, with a reputation for prudent and timely reporting, is…


More on Shoe Zone

Top performers from the retail sector

11/01/2023 · Company Insights

Results and updates covered here include news from two small AIM companies in the retail sector,…


Growth constraints!

25/10/2022 · Company Insights

There was another promising update from a specialist retailer covered here, which has materially ourperformed its…


More on Tortilla Mexican Grill

A tale of 2 investment managers

11/01/2022 · Company Insights

There were positive trading updates from companies covered here, including a couple of relative newcomers to…


AIM new arrivals October 2021

03/11/2021 · Company Insights

October proved to be a big month for resources listings on AIM, including a tungsten and…


More Company Insights

Record results from the social entertainers

Fevertree Drinks: is the valuation justified?

22/03/2023 · Fevertree Drinks PLC

Stonking Small Caps: fabulous results, but…

Sign-up to our free email updates

SIGN UP